Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Effects of the oral, direct factor Xa inhibitor apixaban on routine coagulation assays and anti-Xa assays.

Hillarp, Andreas LU ; Gustafsson, Kerstin M ; Faxälv, Lars ; Strandberg, Karin LU ; Baghaei, Fariba ; Fagerberg Blixter, Inger ; Berndtsson, Maria and Lindahl, Tomas L (2014) In Journal of Thrombosis and Haemostasis 12(9). p.1545-1553
Abstract
Apixaban is an oral direct factor Xa inhibitor developed for prophylaxis and treatment of thromboembolic disorders. Laboratory monitoring is not necessary, but the effects on common coagulation reagents and assays are clinically valuable information.
Please use this url to cite or link to this publication:
author
; ; ; ; ; ; and
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Journal of Thrombosis and Haemostasis
volume
12
issue
9
pages
1545 - 1553
publisher
Elsevier
external identifiers
  • pmid:24965851
  • wos:000342143900023
  • scopus:84908499973
  • pmid:24965851
ISSN
1538-7933
DOI
10.1111/jth.12649
language
English
LU publication?
yes
id
150f5033-6a27-4ea6-81f8-e95b3b964112 (old id 4526750)
alternative location
http://www.ncbi.nlm.nih.gov/pubmed/24965851?dopt=Abstract
date added to LUP
2016-04-01 10:40:18
date last changed
2025-01-14 20:18:45
@article{150f5033-6a27-4ea6-81f8-e95b3b964112,
  abstract     = {{Apixaban is an oral direct factor Xa inhibitor developed for prophylaxis and treatment of thromboembolic disorders. Laboratory monitoring is not necessary, but the effects on common coagulation reagents and assays are clinically valuable information.}},
  author       = {{Hillarp, Andreas and Gustafsson, Kerstin M and Faxälv, Lars and Strandberg, Karin and Baghaei, Fariba and Fagerberg Blixter, Inger and Berndtsson, Maria and Lindahl, Tomas L}},
  issn         = {{1538-7933}},
  language     = {{eng}},
  number       = {{9}},
  pages        = {{1545--1553}},
  publisher    = {{Elsevier}},
  series       = {{Journal of Thrombosis and Haemostasis}},
  title        = {{Effects of the oral, direct factor Xa inhibitor apixaban on routine coagulation assays and anti-Xa assays.}},
  url          = {{http://dx.doi.org/10.1111/jth.12649}},
  doi          = {{10.1111/jth.12649}},
  volume       = {{12}},
  year         = {{2014}},
}